This edition covers a call for input on regulating pharmaceuticals, a reminder on big data focus, Takeda’s digital engagement strategy, three key trends of the mobile revolution, and insights into the state of locum tenens physicians:
– Have a great idea for a policy or guidance document that would stand to benefit the pharmaceutical or biologics industry? Regulatory Focus shares the news that The US Food and Drug Administration’s Medical Policy Council, an offshoot of the Center for Drug Evaluation and Research (CDER), has put out a call for comments in Have an Idea for Better Regulating Pharmaceuticals? FDA Wants to Know
– With all the attention given to big data in the past few years, researchers are being urged to ignore the hype and allure of more information in favor of focusing their efforts and conducting research to answer the questions specific to their business. Quirk’s Bigger (Data) Isn’t Always Better is a reminder that focused data can provide research results that are objective-driven, not numbers-driven
– In Social Media Brings Millennium: The Takeda Oncology Company Closer to People, the latest ‘Pharma gets social’ from pharmaphorum, Daniel Ghinn, Founder and CEO of Creation Healthcare, explores the digital engagement strategy of Millenium: The Takeda Oncology Company, which uses social media to get closer to its patients, patient advocacy groups and healthcare professionals
– Mobile was a means to interact in real time with an increasingly interactive world. The Real Mobile Revolution Isn’t About Mobility from Forbes covers three key trends that have piggy-backed on the mobile revolution and have significantly changed how users consume technology
– According to Staff Care’s “2013 Survey of Temporary Physician Staffing Trends,” over 70% of hospitals and medical groups used locum tenens physicians sometime during the last 12 months. Recruiting Trends’ Health Reform and Temporary Physician Recruiting highlights additional key findings from the report
That wraps this week’s review of news from and for the pharma market research community. I’ll leave you with an invitation to learn more about the benefits of real time data and offer you a personal demo of InCrowd’s on-demand platform providing you direct and immediate access to Crowds of screened and targeted healthcare professionals.
Have a tip, suggestion or resource you’d like to share? Drop us a comment below and please feel free to suggest topics that you would like to see covered in future posts.
